METRO HEALTHCARE BERHAD

KLSE: 0329 (METRO)

Kemas kini terakhir: 4 jam lalu

0.210

-0.01 (-2.33%)

Penutupan Terdahulu 0.215
Jumlah Dagangan 44,100
Harga / Pendapatan (P/E Ke hadapan) 36.63
Harga / Jualan (P/S) 4.02
Harga / Buku (P/B) 2.73
Julat 52 Minggu
0.200 (-4%) — 0.245 (16%)
Hasil Dividen (DY TTM) 2.38%
Margin Keuntungan 6.52%
Margin Operasi (TTM) 7.02%
Pertumbuhan Hasil Suku Tahunan (YOY) -9.20%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -82.70%
Jumlah Hutang/Ekuiti (D/E MRQ) 20.42%
Nisbah Semasa (MRQ) 10.75
Aliran Tunai Operasi (OCF TTM) 6.88 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 4.15 M
Pulangan Atas Aset (ROA TTM) 6.31%
Pulangan Atas Ekuiti (ROE TTM) 5.47%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Care Facilities (MY) Menurun Bercampur
Medical Care Facilities (Global) Menaik Menaik
Stok METRO - -

AISkor Stockmoo

-1.5
Konsensus Penganalisis -2.0
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal -2.5
Osilator Teknikal -2.0
Purata -1.45

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
METRO - 2.38% - 2.73
ALPHA - 2.04% - 6.25
MHCARE - 1.11% - 11.15
TOPVISN - 6.06% - 1.25
IHH - 1.37% - 2.16
SUNMED - - - 7.76

Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia.

Sektor Healthcare
Industri Medical Care Facilities
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 69.24%

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
31 Jul 2026 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
30 Jul 2026 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
27 Jul 2026 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - PUAN ROSE ZILAWATI BINTI MOHAMED ARIFIN
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - MISS CHUA LENG LEEK
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR KONG LAN MOON
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR YEE MENG KHEONG
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - MR SEAH CHEONG WEI
27 Jul 2026 Pengumuman Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
27 Jul 2026 Pengumuman NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES
24 Jul 2026 Pengumuman DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
24 Jul 2026 Pengumuman METRO - BONUS ISSUE OF 244,726,244 NEW WARRANTS IN METRO ("WARRANTS") ON THE BASIS OF 1 WARRANT FOR EVERY 4 EXISTING ORDINARY SHARES HELD ("BONUS ISSUE OF WARRANTS")
21 Jul 2026 TheEdge Metro Healthcare hunkers down to diversify into a multidisciplinary offering
16 Jul 2026 Pengumuman METRO HEALTHCARE BERHAD ("METRO" OR "THE COMPANY") - APPOINTMENT OF AUDITORS
06 Jul 2026 Pengumuman METRO - Notice of Bonus Entitlement
03 Jul 2026 Pengumuman Bonus Issue
02 Jul 2026 Pengumuman NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES
30 Jun 2026 Pengumuman NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES
29 Jun 2026 Pengumuman General Meetings: Outcome of Meeting
29 Jun 2026 Pengumuman General Meetings: Outcome of Meeting
29 Jun 2026 TheEdge The Week Ahead: Eyes on June PMI, Syed Saddiq’s final CBT verdict and Rosmah’s solar graft appeal hearing
Papar semua
Hasil Dividen (DY TTM) 2.38%
Purata Hasil Dividen 1T 2.96%
Nisbah Pembayaran 114.89%
Jangkaan Pembayaran Dividen Seterusnya Oct 2026
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
06 Apr 2026 19 Mar 2026 17 Apr 2026 0.0025 Tunai
03 Oct 2025 19 Sep 2025 16 Oct 2025 0.0025 Tunai
10 Apr 2025 21 Mar 2025 22 Apr 2025 0.004 Tunai

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2026 0.003 1 1.19
2025 0.007 2 2.96

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda